Rythm makes Dreem, a personal neurotechnology headband designed to increase sleep quality. Dreem is available now for $349.00 at Rythm.co and is supported via mobile apps on iOS devices. Led by CEO and co-founder Hugo Mercier, the company is conducting clinical trials with the French Armed Forces Biomedical Research Institute (IRBA) and an academic research team (EA 7330, Hôtel-Dieu, Paris Descartes University) to assess the headband on people with unconventional sleep routines. Rythm raised more than $11m in funding from investors including French entrepreneurs Dr. Laurent Alexandre and Xavier Niel, as well as public grants. The company intends to use the funds to grow operations. Rythm is based in Paris, France and San Francisco.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2016